Vical, Astellas ink licensing deal on vaccine - BusinessWeek

[INCIID News Feed]

<img alt="" height="1" width="1" />
Vical, Astellas ink licensing deal on vaccine
BusinessWeek
Drug developer Vical Inc. said Thursday that it has signed a global licensing agreement with Astellas Pharma Inc. to develop and commercialize a drug aimed at preventing a potentially fatal virus in stem-cell transplant patients. ...
Post-Market NASDAQ Movers (GOOG, VICL, AERL, EXTR, RECN, FLIR, LPHI, SGEN ...International Business Times
Biopharma Vical Signs $130M Licensing Deal On VaccineWall Street Journal
Vical to develop DNA vaccine with Japan&#39;s AstellasReuters
Bloomberg -SignOnSanDiego.com -MarketWatch (press release)
all 20 news articles &raquo;


More...